Back to search

Article

Quality Use Of Medicines In Patients With Chronic Kidney Disease

2020-05-19

Abstract excerpt

<title>Abstract</title> <p><bold><italic>Background:</italic></bold> Chronic kidney disease (CKD) affects drug elimination and patients with CKD require appropriate adjustment of renally cleared medications to ensure safe and effective pharmacotherapy. The main objective of this study was to determine the extent of potentially inappropriate prescribing (PIP; defined as the use of a contraindicated medication or i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e534ce1-f587-5d0e-9c65-33c5a828fc7e
DOI
10.21203/rs.2.16058/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quality Use Of Medicines In Patients With Chronic Kidney DiseaseDOI 10.21203/rs.2.16058/v3
Medication prescribing quality in Australian primary care patients with chronic kidney diseaseSemantic proximity
A systematically collated library of prescribing safety indicators for people with chronic kidney diseaseSemantic proximity
The prevalence of chronic kidney disease in Australian primary care: analysis of a national general practice datasetSemantic proximity
Use of drugs with Pharmacogenomics (PGx)-Based Dosing Guidelines in a Danish Cohort of Persons with Chronic Kidney Disease, Both on Dialysis and Not on Dialysis: Perspectives for Prescribing OptimizationSemantic proximity
Use of complementary and alternative medicine in Shanghai outpatients with chronic kidney disease: a cross-sectional surveySemantic proximity
Estimating the population-level kidney benefits of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease in Australian primary careSemantic proximity
Does it matter how we define chronic kidney disease in primary care? Insights from the observational ATLAS studySemantic proximity
Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: a pharmacovigilance study based on the FAERS databaseSemantic proximity
Associations between chronic kidney disease and mental health disorders and psychoactive drugs in the UK general populationSemantic proximity
Primary Care Physicians’ Practices and Barriers in Evaluating and Managing Chronic Kidney Disease in New Providence, The BahamasSemantic proximity
Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication – an observational study in general practiceSemantic proximity
How well are general practitioners informed about chronic kidney disease?Semantic proximity
Select a neighboring publication to make it the new centre.